Profile data is unavailable for this security.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MustGrow Biologics Corp | 7.54m | -6.37m | 38.34m | 0.00 | -- | 12.34 | -- | 5.09 | -0.1206 | -0.1206 | 0.1435 | 0.0494 | 1.45 | 5.49 | 45.16 | -- | -122.84 | -54.87 | -193.93 | -66.95 | 14.51 | -- | -84.52 | -341.26 | 1.25 | -103.31 | 0.1671 | -- | -91.55 | -- | -622.18 | -- | -- | -- |
| Briacell Therapeutics Corp | 0.00 | -39.14m | 39.96m | 22.00 | -- | 0.7632 | -- | -- | -72.65 | -72.65 | 0.00 | 7.22 | 0.00 | -- | -- | 0.00 | -246.96 | -63.88 | -359.42 | -70.71 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -449.14 | -- | -- | -- |
| ZYUS Life Sciences Corp | 465.00k | -33.74m | 50.70m | 2.00 | -- | -- | -- | 109.04 | -0.4505 | -0.4505 | 0.0062 | -0.1659 | 0.0208 | 0.3346 | 1.17 | -- | -150.55 | -74.90 | -454.68 | -102.81 | 13.12 | 3.61 | -7,256.77 | -8,974.20 | 0.0726 | -9.28 | 6.94 | -- | 37.04 | 313.06 | 20.63 | -- | -- | -- |
| Nurexone Biologic Inc | 0.00 | -8.91m | 61.79m | 9.00 | -- | 28.28 | -- | -- | -0.1196 | -0.1196 | 0.00 | 0.0241 | 0.00 | -- | -- | -- | -208.79 | -215.30 | -263.35 | -529.63 | -- | -- | -- | -- | -- | -102.73 | 0.0514 | -- | -- | -- | -38.58 | -- | -- | -- |
| Sharp Therapeutics Corp | 0.00 | -9.25m | 66.16m | -- | -- | 34.27 | -- | -- | -4.13 | -4.13 | 0.00 | 0.0643 | 0.00 | -- | -- | -- | -435.86 | -- | -512.62 | -- | -- | -- | -- | -- | -- | -- | 0.477 | -- | -- | -- | -2,282.81 | -- | -- | -- |
| Medicenna Therapeutics Corp | 0.00 | -13.82m | 69.23m | 18.00 | -- | 6.76 | -- | -- | -0.1696 | -0.1696 | 0.00 | 0.1228 | 0.00 | -- | -- | 0.00 | -54.21 | -56.44 | -63.31 | -63.20 | -- | -- | -- | -- | -- | -- | 0.0143 | -- | -- | -- | 53.64 | -- | -- | -- |
| Zentek Ltd | 915.32k | -8.19m | 92.47m | 17.00 | -- | 7.71 | -- | 101.03 | -0.0785 | -0.0785 | 0.0088 | 0.1115 | 0.048 | 0.4823 | 5.22 | 53,842.35 | -42.98 | -56.35 | -50.88 | -61.72 | 48.68 | -83.98 | -895.31 | -5,414.02 | 0.5344 | -- | 0.1391 | -- | 2,825.89 | -- | 14.22 | -- | -35.15 | -- |
Data as of Feb 17 2026. Currency figures normalised to Nurexone Biologic Inc's reporting currency: Canadian Dollar CAD
